BioNote Inc
KRX:377740
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
3 985
6 080
|
| Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Income Statement
Earnings Waterfall
BioNote Inc
|
Revenue
|
95.1B
KRW
|
|
Cost of Revenue
|
-48.1B
KRW
|
|
Gross Profit
|
47B
KRW
|
|
Operating Expenses
|
-32.5B
KRW
|
|
Operating Income
|
14.5B
KRW
|
|
Other Expenses
|
67.1B
KRW
|
|
Net Income
|
81.7B
KRW
|
Income Statement
BioNote Inc
| Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||
| Revenue |
566 953
N/A
|
546 841
-4%
|
479 657
-12%
|
224 641
-53%
|
131 976
-41%
|
91 102
-31%
|
90 081
-1%
|
94 216
+5%
|
95 081
+1%
|
|
| Gross Profit | ||||||||||
| Cost of Revenue |
(131 972)
|
(134 445)
|
(138 925)
|
(98 399)
|
(135 057)
|
(123 632)
|
(101 650)
|
(102 804)
|
(48 072)
|
|
| Gross Profit |
434 981
N/A
|
412 396
-5%
|
340 732
-17%
|
126 242
-63%
|
(3 081)
N/A
|
(32 529)
-956%
|
(11 569)
+64%
|
(8 588)
+26%
|
47 009
N/A
|
|
| Operating Income | ||||||||||
| Operating Expenses |
(63 403)
|
(59 926)
|
(45 322)
|
(195 524)
|
(33 922)
|
(52 795)
|
(35 472)
|
(42 671)
|
(32 494)
|
|
| Selling, General & Administrative |
(46 683)
|
(42 957)
|
(28 361)
|
(29 814)
|
(16 643)
|
(11 360)
|
(20 200)
|
(19 105)
|
(17 297)
|
|
| Research & Development |
(15 935)
|
(16 081)
|
(16 138)
|
(17 548)
|
(15 967)
|
(15 563)
|
(13 405)
|
(13 064)
|
(13 121)
|
|
| Depreciation & Amortization |
(783)
|
(883)
|
(823)
|
(951)
|
(1 253)
|
(1 524)
|
(1 867)
|
(2 089)
|
(2 077)
|
|
| Other Operating Expenses |
(1)
|
(6)
|
0
|
(147 211)
|
(59)
|
(24 348)
|
0
|
(8 414)
|
0
|
|
| Operating Income |
371 578
N/A
|
352 470
-5%
|
295 410
-16%
|
(69 282)
N/A
|
(37 003)
+47%
|
(85 324)
-131%
|
(47 041)
+45%
|
(51 259)
-9%
|
14 515
N/A
|
|
| Pre-Tax Income | ||||||||||
| Interest Income Expense |
375 658
|
346 258
|
253 517
|
109 621
|
(9 768)
|
(94 638)
|
(54 600)
|
(8 673)
|
11 034
|
|
| Non-Reccuring Items |
(114 169)
|
(131 380)
|
(147 264)
|
0
|
(41 503)
|
0
|
(8 409)
|
0
|
(18)
|
|
| Gain/Loss on Disposition of Assets |
(57)
|
13 421
|
13 419
|
13 417
|
13 389
|
267
|
271
|
(70)
|
197
|
|
| Total Other Income |
(262)
|
(291)
|
(304)
|
(66)
|
(124)
|
(131)
|
288
|
172
|
49
|
|
| Pre-Tax Income |
632 749
N/A
|
580 478
-8%
|
414 778
-29%
|
53 690
-87%
|
(75 009)
N/A
|
(179 825)
-140%
|
(109 491)
+39%
|
(59 830)
+45%
|
25 777
N/A
|
|
| Net Income | ||||||||||
| Tax Provision |
(135 704)
|
(115 815)
|
(106 980)
|
(16 597)
|
6 037
|
23 851
|
88 994
|
79 003
|
55 874
|
|
| Income from Continuing Operations |
497 045
|
464 663
|
307 798
|
37 093
|
(68 973)
|
(155 974)
|
(20 497)
|
19 173
|
81 651
|
|
| Net Income (Common) |
497 045
N/A
|
464 663
-7%
|
307 798
-34%
|
37 093
-88%
|
(68 973)
N/A
|
(155 974)
-126%
|
(20 497)
+87%
|
19 173
N/A
|
81 651
+326%
|
|
| EPS (Diluted) |
4 878.92
N/A
|
4 561.06
-7%
|
3 021.3
-34%
|
364.09
-88%
|
-676.39
N/A
|
-1 529.08
-126%
|
-200.99
+87%
|
187.86
N/A
|
800.06
+326%
|
|
You don't have any saved screeners yet
